James Wright

Director, Global Commercial Marketing @FrancisMedical. Doting Daddy of 2, Loving Husband of 1. Own views, Like/RT is not an endorsement!

[Francis Medical @FrancisMedical]

💧The first commercial #Vanquish® procedure has been performed by @AbhinavSidana at @UChicagoMed, bringing a new #MinimallyInvasive option to patients in the Chicago area.

More: https://t.co/jCvVyOjhuy

Rx Only. FDA Cleared. See https://t.co/herXSlp9hw for safety info.

#Urology

[Francis Medical @FrancisMedical]

💦 Momentum builds!

Naveen Kella, MD, of @theurologyplace, performed the first commercial procedures in San Antonio, TX, using the #Vanquish® Water Vapor Ablation System.

➡️ PR: https://t.co/ktxh9ey0aX

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.
#Urology

[Francis Medical @FrancisMedical]

🚀 As adoption continues to grow, we’re proud to announce the first commercial (non-clinical trial) procedure in the Midwest using the Vanquish® Water Vapor Ablation System.

The procedure was performed by @aaron_milbank, MD, of @MN_Urology at High Pointe Surgery Center in Lake Elmo, Minnesota, marking the first use of the Vanquish System in routine clinical practice in the region.

Developed by Francis Medical, the #Vanquish System is designed to ablate targeted prostate tissue using high-energy sterile water vapor delivered via a transurethral approach.

Thank you to Dr. Milbank, Minnesota Urology, and High Pointe Surgery Center for their collaboration and leadership in bringing this #Innovation into routine clinical practice for select patients.

Congratulations to all involved in reaching this important milestone.

Read more: https://t.co/g29Fc4qui8

Rx Only. FDA Cleared. See https://t.co/MrHkk7dxbK for safety information.

#FirstProcedure #Urology

[Francis Medical @FrancisMedical]

Looking back at the European Association of Urology Congress (#EAU26), we’re grateful for the opportunity to connect with the urology community during an evening focused on advancing care.

Thank you to everyone who joined us for the dinner and presentation, and to Dr. Arvin George for sharing insights from the #VAPOR2 Study on patient experience. This novel, multi-center trial is evaluating the #Vanquish® Water Vapor Ablation System, a transurethral thermal water vapor approach to ablate prostate tissue, with data now reported on the first 110 patients at 12-month follow-up.

We appreciate the engagement and thoughtful discussion around emerging, evidence-based approaches to care.

Explore the evidence: https://t.co/qumEwS2mt2

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.
#ThankYou @Uroweb @arvinkgeorge

[Francis Medical @FrancisMedical]

“We evaluate emerging technologies carefully to ensure they align with our clinical standards, safety, and patient-centered approach to deliver minimally invasive options supported by clinical evidence and responsible adoption.” — Dr. Rahul Mehan

At Francis Medical, advancing innovation starts with evidence. The clinical foundation behind the Vanquish® System reflects a commitment to safety, thoughtful adoption, and delivering meaningful outcomes for patients.

➡️ Explore the #VAPOR2 Study evidence and learn more in the press release: https://t.co/qumEwS2UiA

Rx Only. FDA Cleared. See https://t.co/MrHkk7dxbK for safety information.
#Vanquish @RahulMehan1 @EVUCENTER

[Francis Medical @FrancisMedical]

Momentum continues to build for the Vanquish® Water Vapor Ablation System with expanded commercial use in the Southeastern United States.

Recent procedures were successfully performed in Atlanta, Georgia, by Drs. Neal Patel and Jason Lomboy of Advanced Urology at Johns Creek Surgery Center and Marietta Surgery Center, respectively.

Developed by Francis Medical, the #Vanquish System delivers high-energy sterile water vapor via a transurethral approach to ablate targeted prostate tissue.

Thank you to Dr. Patel, Dr. Lomboy, Advanced Urology, and the teams at Johns Creek and Marietta Surgery Centers for their leadership in advancing #PatientCare.

Learn more: https://t.co/7SPGJxMQ4g

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.
#Urology #Innovation @itsdrpatel @AdvancedUroGA

[Francis Medical @FrancisMedical]

We’re proud to announce the first commercial (non-clinical trial) procedures in Arizona using the #Vanquish® Water Vapor Ablation System.

The procedures were performed by Rahul Mehan, MD, of East Valley Urology Center of Arizona at Verve Surgery Center, marking the first use of the Vanquish System in routine commercial practice in the state.

This milestone reflects thoughtful adoption, physician training, and a shared commitment to advancing minimally invasive procedural innovation.

Developed by Francis Medical, the Vanquish System is intended for the ablation of prostate tissue using high-energy sterile water vapor delivered via a transurethral approach.

#ThankYou to Dr. Mehan (@RahulMehan1 ), Verve Surgery Center, and East Valley Urology Center (@EVUCENTER) of Arizona, whose support helped make this milestone possible.

Congratulations to all involved in leading the way.

Read more about this exciting news. 📄 Press Release: https://t.co/BPZGQos76G

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.

#FirstProcedure

[Francis Medical @FrancisMedical]

What are the advantages of a procedure using the #Vanquish® Water Vapor Ablation System?

#VAPOR2 Study results demonstrated:
☑️ Outpatient procedure (ASC or hospital)
☑️ Majority of patients experience almost no pain
☑️ Minimal impact on daily activities during recovery
☑️ Minimal urinary incontinence
☑️ Low rates of erectile dysfunction
☑️ Allows for future prostate procedures, if necessary

Discover more about this new option for men: https://t.co/PND3cY2R5F

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.

#ProstateHealth #Urology #MinimallyInvasive #FocalTherapy

[Francis Medical @FrancisMedical]

“This breakthrough technology holds the promise of minimizing the life-altering side effects commonly encountered with conventional, more aggressive prostate treatments.”
— Dr. Christopher Dixon

💦 Water vapor technology is designed to ablate prostate tissue with the thermal energy stored in sterile water vapor. The #Vanquish® #WaterVaporAblation System delivers targeted applications of thermal energy using a transurethral procedure.

See the science behind this approach: https://t.co/LKRUWzuX45

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.
#MinimallyInvasive

[Francis Medical @FrancisMedical]

“The patient satisfaction data further supports the exciting potential of the Vanquish technology,” said Dr. Arvin George (@arvinkgeorge), director of Prostate Cancer Programs at the Brady Urological Institute, Johns Hopkins University, and a VAPOR 2 co-principal investigator. “Most patients experienced no pain, quickly resumed daily activities, and indicated high rates of satisfaction with their procedure and decision at 12 months.”

Echoing #VAPOR2 Study results: 93% of patients were extremely satisfied or satisfied at 12 months, with minimal to no pain reported.

The #Vanquish® System is cleared for thermal ablation of targeted prostate tissue via transurethral approach.

🔗 More: https://t.co/MrHkk7cZmc

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.

#ProstateHealth #Urology #MedTech #Innovation @brady_urology

[Francis Medical @FrancisMedical]

💦 We’re proud to celebrate the first Vanquish® procedure in routine commercial practice on the East Coast.

Performed by Dr. Robert Given of Urology of Virginia at Chesapeake Regional Surgery Center, this milestone reflects continued momentum as physicians bring this innovative, minimally invasive option into everyday practice.

Thank you to Dr. Given, Urology of Virginia, and Chesapeake Regional Surgery Center for advancing care and expanding access. Congratulations to all involved!

Learn more in the full press release: 👉 https://t.co/vysoHY8X57

Developed by Francis Medical, the #Vanquish System is designed to ablate prostate tissue using high-energy sterile water vapor delivered via a transurethral approach.

Rx Only. FDA Cleared. See https://t.co/MrHkk7cZmc for safety information.

#FirstProcedure #Innovation @UrologyofVA

[Srinivas Vourganti, MD @vourganti]

This is a trial to watch: @arvinkgeorge presents an update to the Vapor2 trial (Vanquish System) which aims to destroy prostate tissue with steam. So far it appears to be quite compelling in the tissue ablation space. #EAU26

[James Wright @JWrightMedTech]

It was a beautiful morning along the Thames supporting @europa_uomo #StepOutForCancer alongside colleagues and peers from @Uroweb during #EAU2026 #London raising awareness and vital €€€ for #ProstateCancer charitable causes. Congrats to all who participated and organized ❤️

[Francis Medical @FrancisMedical]

🏃‍♂️As the sun rises in London, the urology community is starting the day with the European Association of Urology Congress (#EAU26) Prostate Cancer Run – Step Out for Prostate Cancer.

Participants are starting the morning with a walk or run alongside colleagues from across the field.

Good luck to everyone participating! We’ll be cheering you on, including our own James Wright - @JWrightMedTech.

Learn who we are and why we do what we do: https://t.co/e8OEhUbETy

RX Only. FDA Cleared. See https://t.co/MrHkk7dxbK for safety information.
#Urology @Uroweb

[European Association of Urology (EAU) @Uroweb]

For short (<3 cm) bulbar strictures recurring after ≥2 endoscopic treatments, consider drug-coated balloon dilatation (paclitaxel):

📊 ROBUST-3: 6-mo patency 75% vs 27%, 1-yr retreatment-free 83% vs 22%
🔒 For those unfit for urethroplasty

#Strictures #EAUGuidelines

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Congratulations to Dr. John Ward and team @MDAndersonNews on completing our first TULSA-PRO procedure - a customizable, MRI-guided, incision-free ultrasound ablation representing an additional option for select patients with #ProstateCancer #OncSurgery

[KIMS Hospitals @kimshospitals]

��� Congratulations to the Urology & Radiology teams for successfully ablating 3 prostate cancer cases on launch day! KIMS Hospitals, Secunderabad is now the first Tulsa-Pro Center in India !
Tulsa-Pro brings advanced, minimally invasive treatment for prostate cancer, ensuring precision, safety, and quicker recovery.

To know more about TULSA-Pro, please call us at 083748 54559 or visit https://t.co/buN1F1KLzC

#KIMSHospitals #TulsaPro #FirstInIndia #SouthAsia #ProstateCancer #Urology #Radiology #MedicalInnovation #minimallyinvasive #ProstateCare #MRIGuidance #BPHCare #Urologists #MensHealth #HealthcareExcellence #Secunderabad

[Optilume @OptilumeDCB]

"Optilume is a game changer." - Dr. Wiegand
See how this breakthrough urethral stricture treatment is providing long-lasting relief for patients. Watch the video now.

#Urology #MensHealth #Optilume #PatientCare #StrictureDisease

[Optilume @OptilumeDCB]

For #MensHealthMonth, explore how Optilume® is advancing urethral stricture treatment. A breakthrough for urologists and their patients. Watch the video below!
#Urology #MensHealth #Optilume #MensHealthMonth #Movember

[James Wright @JWrightMedTech]

Congrats @HillUrology and the #Urology team @StockportNHS Delivering #Innovation in the form of #OptilumeUrethralDCB for the treatment of anterior #UrethralStricture

[Stepping Hill Urology @HillUrology]

First 6 patients for Optilume @HillUrology this morning! Well done Prof Sinclair and super team @SteppingHillMOT

[James Wright @JWrightMedTech]

@HillUrology @SteppingHillMOT Love this! Congrats @HillUrology and Mr. Sinclair. Wishing the patients a speedy recovery and a #UrethralStricture free future